Supplementary Tables from TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup
Year: 2023
Type: supplementary-materials
Abstract: Supplement Table 1: Prostate cancer cohorts used for genome wide expression profiling Supplement Table 2: GSEA Hallmark - Significant enrichments Supplement Table 3: GSEA Oncogenic Signatures - Significant enrichments Supplement Table 4: Dana Farber Cancer Institute tissue microarray (TMA) sample information Supplement Table 5: Differentially expressed genes (DEG) Supplement Table 6: Overlapping differentially expressed genes (DEG) Supplement Table 7: Univariate survival analysis including TOP2A/EZH2 expression together with other variables and their association on clinical outcomes (Meta Cohort, N = 631) Supplement Table 8: Multivariate survival analysis including TOP2A/EZH2 expression together with standard clinical variables and their association on clinical outcomes (meta cohort, N = 631) Supplement Table 9: Multivariate survival analysis including TOP2A/EZH2 expression together with Decipher and standard clinical variables and their association on clinical outcomes (Meta Cohort, N = 631)
Authors: David P. Labbé, Christopher J. Sweeney, Myles Brown, Phillip Galbo, Spencer Rosario, Kristine M. Wadosky, Sheng-Yu Ku, Martin Sjöström, Mohammed Alshalalfa, Nicholas Erho, Elai Davicioni, R. Jeffrey Karnes, Edward M. Schaeffer, Robert B. Jenkins, Robert B. Den, Ashley E. Ross, Michaela Bowden, Ying Huang, Kathryn P. Gray, Felix Y. Feng, Daniel E. Spratt, David W. Goodrich, Kevin H. Eng, Leigh Ellis
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361922630